@article{cd8c4876293f440e84e48d6053d8b6d0,
title = "SMA Patient Experienced Aseptic Meningitis With Severe Hypoglycorrhachia After Nusinersen Infusion (2528)",
author = "Afra Janarious and Ali Habib and Tahseen Mozaffar and Korb, \{Manisha Kak\}",
note = "Objective: To discuss the finding of aseptic meningitis with severe hypoglycorrhachia in an adult patient receiving Nusinersen. Background: Nusinersen is the first FDA-approved drug for spinal muscular atrophy (SMA), an autosomal recessive motor neuron disorder causing severe progressive motor weakness in children and adults.",
year = "2020",
month = apr,
day = "14",
language = "American English",
volume = "94",
journal = "Neurology",
}